Skip to main content
SpringerLink
Log in

Polymorphisms of Genes Associated with Intracellular Signaling Pathways in Juvenile Idiopathic Arthritis

  • Published:
Cytology and Genetics Aims and scope Submit manuscript

Abstract

The aim of the study was to determine nucleotide sequence changes in the genes associated with the activation of intracellular signaling molecules and the risk of autoimmune dysregulation in patients with juvenile idiopathic arthritis (JIA). High-throughput panel-exome next-generation sequencing (NGS) was performed using the high-throughput Illumina HiSeq system (United States) in 36 children diagnosed with JIA. Nucleotide sequence changes were detected in the CASP10, CASP8, IL7R, IL10RA, IL12RB1, IL21R, MYD88, NFKB2, STAT5B, JAK3, IRAK4, and UNC13D genes in 13 (36.11%) patients, including seven (53.8%) children with nucleotide sequence changes associated with autoinflammatory syndromes (NOD2, NLRP12, MEFV, ADA2, and PSTPIP1). The seven HLA-B27-positive (53.8%) patients had changes in autoimmunity genes, whereas only two (8.6%) children had no changes in these genes, which showed associativity between HLA and the group of selected genes (OR = 12.25 (MukvichCI 1.99–75.19)). Thus, the risk loci were identified in 36.11% of patients with the JIA phenotype in the CASP10, CASP8, IL7R, IL10RA, IL12RB1, IL21R, MYD88, NFKB2, STAT5B, JAK3, IRAK4, and UNC13D genes associated with the activation of intracellular signaling molecules and the initiation of autoimmune dysregulation. The patients with JIA with nucleotide sequence changes in the autoimmunity genes developed mutations in the autoinflammatory genes significantly more frequently, which demonstrated a possibility for developing a combined overlapping autoimmune–autoinflammatory phenotype in definite individuals. The study confirms the significance of variative changes in the NFkB and JAK/STAT genes of intracellular signaling pathways for the onset of JIA, which may be informative for the development of future therapeutic strategies as well as for the personalization of therapeutic decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Arakelyan, A., Nersisyan, L., Poghosyan, D., Khondkaryan, L., Hakobyan, A., Löffler-Wirth, H., Melanitou, E., and Binder, H., Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles, PLoS One, 2017, vol. 12, no. 3, art. ID e0187572.

    Article  Google Scholar 

  2. Banerjee, S., Biehl, A., Gadina, M., et al., JAK–STAT Signaling as a target for inflammatory and autoimmune diseases: Current and future prospects, Drugs, 2017, vol. 77, pp. 521–546. https://doi.org/10.1007/s40265-017-0701-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Baralle, D. and Baralle, M., Splicing in action: assessing disease causing sequence changes, J. Med. Genet., 2005, vol. 42, no. 10, pp. 737–748. PMID: 16199547; PMCID: PMC1735933.https://doi.org/10.1136/jmg.2004.029538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Buratti, E., Chivers, M., Královicová, J., et al., Aber-rant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization, Nucleic Acids Res., 2007, vol. 35, no. 13, pp. 4250–4263. https://doi.org/10.1093/nar/gkm402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ciccarelli, F., De Martinis, M., and Ginaldi, L., An update on autoinflammatory diseases, Curr. Med. Chem., 2014, vol. 21, no. 3, pp. 261–269.

    Article  CAS  Google Scholar 

  6. Conway, D.H., Dara, J., Bagashev, A., and Sullivan, K.E., Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred, J. Allergy Clin. Immunol., 2010, vol. 126, no. 1, pp. 172–175. doi . Cited June 9, 2010. PMID: 20538326https://doi.org/10.1016/j.jaci.2010.04.014

  7. Felgentreff, K., Perez-Becker, R., Speckmann, C., et al., Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency, Clin. Immunol., 2011, vol. 141, no. 1, pp. 73–82.https://doi.org/10.1016/j.clim.2011.05.007

    Article  CAS  PubMed  Google Scholar 

  8. Pagnini, I., Scavone, M., Maccora, I., Mastrolia, M.V., Marrani, E., Bertini, F., Lamot, L., and Simonini, G., The development of extra-articular manifestations in children with enthesitis-related arthritis: natural course or different disease entity?, Front. Med., 2021, vol. 8, art. ID 667305.

    Article  Google Scholar 

  9. Jie, Li., Rong-Shuang, T., Zhou, Shi., and Jin-Qi, Li., Nuclear factor-κB in rheumatoid arthritis, Int. J. Reumatic Dis., 2020, vol. 23, no. 12, pp. 1627–1635. https://doi.org/10.1111/1756-185X.13958

    Article  CAS  Google Scholar 

  10. McAllister, K., Eyre, S., and Orozco, G., Genetics of rheumatoid arthritis: GWAS and beyond, Open Access Rheumatol., 2011, vol. 3, pp. 31–46.

    PubMed  PubMed Central  Google Scholar 

  11. Kobayashi, Y., Yang, S., Nykamp, K., Garcia, J., Lincoln, S.E., and Topper, S.E., Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation, Genome Med., 2017, vol. 9, no. 1, art. ID PMCID: PMC5295186.https://doi.org/10.1186/s13073-017-0403-7

  12. Leiding, J.W., et al., Hypomorphic interleukin-7 receptor α-chain mutations and T-cell deficiency: a delay in diagnosis, Ann. Allergy, Asthma, Immunol., 2015, vol. 115, no. 1, pp. 1–3. PMID: 26123418.

    Article  Google Scholar 

  13. Harigai, M. and Honda, S., Selectivity of Janus kinase Inhibitors in rheumatoid arthritis and other immune-mediated inflammatory diseases: is expectation the root of all headache?, Drugs, 2020, vol. 80, no. 12, pp. 1183–1201.

    Article  CAS  Google Scholar 

  14. Oliveira, M.L., Akkapeddi, P., Ribeiro, D., Melão, A., and Barata, J.T., IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update, Adv. Biol. Regul., 2019, vol. 71, pp. 88–96. https://doi.org/10.1016/j.jbior.2018.09.012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. O’Shea, J.J. and Plenge, R., JAK and STAT signaling molecules in immunoregulation and immune-mediated disease, Immunity, 2012, vol. 36, no. 4, pp. 542–550.https://doi.org/10.1016/j.immuni.2012.03.014

  16. Salim, P.H. and Xavier, R.M., Influence of genetic polymorphisms (IL-10/CXCL8/CXCR2/NFκB) on the susceptibility of autoimmune rheumatic diseases, Rev. Bras. Reumatol., 2014, vol. 54, no. 4, pp. 301–310.

    Article  Google Scholar 

  17. Petty, R.E., Southwood, T.R., and Manners, P., International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision Edmonton, 2001, J. Rheumatol., 2004, vol. 31, no. 2, pp. 390–392. PMID: 14760812.

    PubMed  Google Scholar 

  18. Picard, C., von Bernuth, H., Ghandil, P., et al., Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency, Medicine (Baltimore), 2010, vol. 89, no. 6, pp. 403–425. https://doi.org/10.1097/MD.0b013e3181fd8ec3

    Article  CAS  PubMed  Google Scholar 

  19. Robinson, R.T., IL12Rβ1: The cytokine receptor that we used to know, Cytokine, 2015, vol. 71, no. 2, pp. 348–359. https://doi.org/10.1016/j.cyto.2014.11.018

    Article  CAS  PubMed  Google Scholar 

  20. Ringold, S., Sheila, T., Angeles-Han, et al., American College of Rheumatology/Arthritis Foundation Guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis, Arthritis Care Res., 2019, vol. 71, no. 6, pp. 717–734. https://doi.org/10.1002/acr.23870

    Article  Google Scholar 

  21. Sikora, K.A., Bennett, J.R., Vyncke, L., et al., Germline gain-of-function myeloid differentiation primary response gene–88 (MYD88) mutation in a child with severe arthritis, J. Allergy Clin. Immunol., 2018, vol. 141, no. 5, pp. 1943–1947. https://doi.org/10.1016/j.jaci.2018.01.027

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tripodi, S.I., Mazza, C., Moratto, D., Ramenghi, U., Caorsi, R., Gattorno, M., and Badolato, R., Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation, Immunol. Lett., 2016, vol. 177, pp. 22–24. https://doi.org/10.1016/j.imlet.2016.07.001

    Article  CAS  PubMed  Google Scholar 

  23. Wieczorek, M., Ginter, T., Brand, P., Heinzel, T., and Krämer, O.H., Acetylation modulates the STAT signaling code, Cytokine Growth Factor Rev., 2012, vol. 23, no. 6, pp. 293–305. https://doi.org/10.1016/j.cytogfr.2012.06.005

    Article  CAS  PubMed  Google Scholar 

  24. Yang, J. and Stark, G., Roles of unphosphorylated STATs in signaling, Cell Res., 2008, vol. 18, pp. 443–451. https://doi.org/10.1038/cr.2008.41

    Article  CAS  PubMed  Google Scholar 

  25. Yasunaga, M., Manabe, S., and Matsumura, Y., Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease, Sci. Rep., 2017, vol. 7, art. ID 10735. https://doi.org/10.1038/s41598-017-11255-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zhu, S., Hsu, A.P., Vacek, M.M., Zheng, L., Schäffer, A.A., Dale, J.K., Davis, J., Fischer, R.E., Straus, S.E., Boruchov, D., Saulsbury, F.T., Lenardo, M.J., and Puck, J.M., Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome, Hum. Genet., 2006, vol. 119, no. 3, pp. 284–294.https://doi.org/10.1007/s00439-006-0138-9

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study has not been supported by any particular grant from any financial establishments of the state, commercial, or noncommercial sectors.

Author information

Authors and Affiliations

  1. Luk’yanova Institute of Pediatrics, Obstetrics and Gynecology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

    O. M. Mukvich & A. M. Matskevych

  2. Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine

    G. D. Telegeev

  3. Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine

    A. M. Gilfanova

Authors
  1. O. M. Mukvich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. D. Telegeev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. Matskevych
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. M. Gilfanova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to O. M. Mukvich, G. D. Telegeev, A. M. Matskevych or A. M. Gilfanova.

Ethics declarations

Conflict of interest. The authors declare that they have no conflicts of interest.

Statement of compliance with standards of research involving humans as subjects. The studies were performed in compliance with good clinical practice (GCP) recommendations (1996), the Convention on Human Rights and Biomedicine (April 4, 1997), the World Medical Association Declaration of Helsinki (1964–2002), the Order of the Ministry of Health of Ukraine no. 281 of November 1, 2001, the Protocol of the study approved by the Local Ethics Committee for patients and parents participating in the study based on the Luk’yanova Institute of Pediatrics, Obstetrics and Gynecology, National Academy of Medical Sciences of Ukraine, and Protocol no. 7 of November 13, 2018. Each of the participants included in the study gave his or her informed voluntary consent. This article contains no investigations with the use of animals as the study objects. The statistical data treatment included only nonpersonified data on patients.

Additional information

Translated by N. Tarasyuk

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukvich, O.M., Telegeev, G.D., Matskevych, A.M. et al. Polymorphisms of Genes Associated with Intracellular Signaling Pathways in Juvenile Idiopathic Arthritis. Cytol. Genet. 56, 226–235 (2022). https://doi.org/10.3103/S0095452722030070

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0095452722030070

Search

Navigation